Ocugen | EFFECT: Others
May 2 18:08
Ocugen | 10-K/A: Annual report (Amendment)
Apr 30 05:29
Ocugen | 8-K: Current report
Apr 29 20:03
Ocugen | S-3: Registration statement for specified transactions by certain issuers
Apr 19 02:18
Ocugen | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Apr 19 02:18
Ocugen | 4: Statement of changes in beneficial ownership of securities-Officer Qamar Huma
Apr 18 05:45
Ocugen | 10-K: Annual report
Apr 17 03:50
Ocugen | 8-K: Ocugen Announces U.S. Food and Drug Administration Approval of IND Amendment to Initiate OCU400 Phase 3 Clinical Trial
Apr 9 01:17
Ocugen | 8-K: Ocugen Reports Year End 2023 Financial Results and Provides Corporate Update
Apr 2 21:29
Ocugen | 8-K: Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
Apr 2 05:15
Ocugen | NT 10-K: Others
Apr 2 05:09
Ocugen | 8-K: United States Court of Appeals for the Third Circuit Affirmed the Decision of Consolidated Securities Class Action Lawsuit
Mar 22 04:24
Ocugen | 3: Initial statement of beneficial ownership of securities-Officer Qamar Huma
Mar 21 06:13
Ocugen | 3: Initial statement of beneficial ownership of securities-Officer Breininger Michael
Mar 21 06:03
Ocugen | 8-K: Director Patrick Grady Will Not Run For Re-Election At The 2024 Shareholder Meeting
Mar 21 05:18
Ocugen | 8-K: Ocugen Announces Appointment of Huma Qamar as Chief Medical Officer
Mar 18 20:54
Ocugen | 8-K: Presentation of an In-Person Clinical Showcase at the Nasdaq Market Site in Times Square
Feb 22 00:26
Ocugen | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(4.69%)
Feb 14 11:42
Ocugen | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-STATE STREET CORPORATION(0.33%)
Jan 22 13:00
Ocugen | 8-K: Ocugen Grants Performance-Based Restricted Stock Units to Incentive Recipients
Jan 8 13:00
No Data
No Data